Index | Ligand Name | Structure | PDB code | ligand desolvation |
1 | 443 | Discovery of Tetrahydropyrimidin-2(1H)-one derivative TAK-442: A potent, selective and orally active factor Xa inhibitor | 3kl6 | 84.52 |
2 | a7i | Factor Xa in complex with a potent 2-amino-ethane sulfonamide inhibitor | 4a7i | 83.1 |
3 | h25 | Aminopyrrolidine Factor Xa inhibitor | 2vwn | 82.91 |
4 | lzg | Aminopyrrolidine Factor Xa inhibitor | 2vwo | 82.33 |
5 | 455 | Factor Xa in complex with a pyrrolidine-3,4-dicarboxylic acid inhibitor | 2xbw | 82 |
6 | d46 | factor Xa in complex with D46-5241 | 3tk6 | 81.77 |
7 | riv | Factor Xa in complex with BAY59-7939 | 2w26 | 81.62 |
8 | me5 | Factor xa in complex with the inhibitor 5-chloro-N-((1R,2S)-2-(4-(2-oxopyridin-1(2H)-YL)benzamido) cyclopentyl)thiophene-2-carboxamide | 2p95 | 81.51 |
9 | lzh | Aminopyrrolidine Factor Xa inhibitor | 2vwl | 81.39 |
10 | xbv | Factor Xa in complex with a pyrrolidine-3,4-dicarboxylic acid inhibitor | 2xbv | 81.17 |
11 | riv | DesGla-XaS195A Bound to Aptamer 11F7t and Rivaroxaban | 5vof | 81.09 |
12 | 784 | Factor Xa - cation | 2bok | 80.76 |
13 | lzf | Aminopyrrolidine Factor Xa inhibitor | 2vvc | 80.66 |
14 | iia | Crystal structure of factor Xa in complex with compound ""1"" | 2boh | 80.43 |
15 | d90 | Factor Xa in complex with a phenylenediamine derivative | 3q3k | 80.32 |
16 | rrr | CRYSTAL STRUCTURE OF HUMAN COAGULATION FACTOR XA COMPLEXED WITH RPR209685 | 1nfw | 80.25 |
17 | 701 | Selective and Dual Action Orally Active Inhibitors of Thrombin and Factor Xa | 2uwo | 80.09 |
18 | rtr | CRYSTAL STRUCTURE OF HUMAN COAGULATION FACTOR XA COMPLEXED WITH RPR200095 | 1nfy | 79.85 |
19 | iib | Crystal structure of factor Xa in complex with 21 | 2bq6 | 79.84 |
20 | iie | CRYSTAL STRUCTURE OF FACTOR XA IN COMPLEX WITH COMPOUND 45 | 2bqw | 79.83 |
21 | ivk | Factor Xa in complex with a pyrrolidine-3,4-dicarboxylic acid inhibitor | 2xc4 | 79.78 |
22 | oyj | Factor Xa in complex with a pyrrolidine-3,4-dicarboxylic acid inhibitor | 2xc5 | 79.78 |
23 | 4o5 | Factor Xa complex with GTC000102 | 4zha | 79.75 |
24 | h21 | Aminopyrrolidine-related triazole Factor Xa inhibitor | 2vvv | 79.62 |
25 | fxv | Crystal Structure of Human Coagulation Factor XA Complexed with FXV673 | 1ksn | 79.5 |
26 | 48u | Factor Xa complex with GTC000101 | 4y6d | 79.33 |
27 | d91 | Factor Xa in complex with the inhibitor 4-[(5-chloroindol-2-yl)sulfonyl]-2-(2-methylpropyl)-1-[[5-(pyridin-4-yl) pyrimidin-2-yl]carbonyl]piperazine | 1wu1 | 79.31 |
28 | rr8 | Factor Xa in complex with a pyrrolidine-3,4-dicarboxylic acid inhibitor | 2xbx | 79.27 |
29 | me1 | Factor xa in complex with the inhibitor 5-chloro-N-(2-(4-(2-oxopyridin-1(2H)-yl)benzamido)ethyl)thiophene-2-carboxamide | 2p93 | 79.25 |
30 | fjd | FACTOR XA - CATION INHIBITOR COMPLEX | 2y5g | 79.06 |
31 | d93 | FACTOR XA IN COMPLEX WITH THE INHIBITOR trans-N1-[(5-Chloroindol-2-yl)carbonyl]-N2-[(5-methyl-4,5,6,7-tetrahydrothiazolo[5,4-c]pyridin-2-yl)carbonyl]-1,2-cyclohexanediamine | 2ei7 | 78.87 |
32 | gg2 | Factor Xa in Complex with the Inhibitor APIXABAN (BMS-562247) AKA 1-(4-METHOXYPHENYL)-7-OXO-6-(4-(2-OXO-1-PIPERIDINYL)PHENYL)-4,5,6,7-TETRAHYDRO-1H-PYRAZOLO[3, 4-C]PYRIDINE-3-CARBOXAMIDE | 2p16 | 78.83 |
33 | d01 | Factor Xa in complex with the inhibitor 2-[[4-[(5-chloroindol-2-yl)sulfonyl]piperazin-1-yl] carbonyl]thieno[3,2-b]pyridine n-oxide | 2d1j | 78.79 |
34 | h22 | Aminopyrrolidine Factor Xa inhibitor | 2vvu | 78.74 |
35 | gsq | CRYSTAL STRUCTURE OF A HUMAN FACTOR XA INHIBITOR COMPLEX | 2j2u | 78.73 |
36 | 63c | Factor Xa in complex with a pyrrolidine-3,4-dicarboxylic acid inhibitor | 2xby | 78.69 |
37 | 663 | Crystal structure of human factor XA complexed with 3-chloro-N-(4-chloro-2-{[(5-chloropyridin-2-yl)amino]carbonyl}-6-methoxyphenyl)-4-[(1-methyl-1H-imidazol-2-yl)methyl]thiophene-2-carboxamide {Pfizer 320663} | 2p3u | 78.44 |
38 | gsk | Crystal structure of a Human Factor Xa inhibitor complex | 2cji | 78.4 |
39 | iid | Crystal structure of factor Xa in complex with 43 | 2bq7 | 78.37 |
40 | 4pp | FACTOR XA COMPLEXED WITH A SYNTHETIC INHIBITOR FX-2212A,(2S)-(3'-AMIDINO-3-BIPHENYLYL)-5-(4-PYRIDYLAMINO)PENTANOIC ACID | 1xka | 78.27 |
41 | xlc | Crystal Structure of 3-chloro-N-[4-chloro-2-[[(4-chlorophenyl)amino]carbonyl]phenyl]-4-[(4-methyl-1-piperazinyl)methyl]-2-thiophenecarboxamide Complexed with Human Factor Xa | 1mq5 | 78.26 |
42 | 4o6 | Factor Xa complex with GTC000406 | 4y79 | 78.17 |
43 | g15 | CRYSTAL STRUCTURE OF A HUMAN FACTOR XA INHIBITOR COMPLEX | 2j94 | 78.11 |
44 | 894 | Factor Xa inhibitor complex | 2uwp | 78.06 |
45 | yet | Crystal structure of human FxA in complex with (S)-2-cyano-1-(2-methylbenzofuran-5-yl)-3-(2-oxo-1-(2-oxo-2-(pyrrolidin-1-yl)ethyl)azepan-3-yl)guanidine | 3hpt | 77.94 |
46 | l1c | Crystal Structure of FXa in complex with 4,4-disubstituted pyrrolidine-1,2-dicarboxamide inhibitor 2 | 2w3i | 77.94 |
47 | gsx | CRYSTAL STRUCTURE OF A HUMAN FACTOR XA INHIBITOR COMPLEX | 2j95 | 77.89 |
48 | gs6 | CRYSTAL STRUCTURE OF A HUMAN FACTOR XA INHIBITOR COMPLEX | 2j34 | 77.84 |
49 | 895 | Selective and Dual Action Orally Active Inhibitors of Thrombin and Factor Xa | 2uwl | 77.59 |
50 | gs5 | CRYSTAL STRUCTURE OF A HUMAN FACTOR XA INHIBITOR COMPLEX | 2j38 | 77.47 |
51 | 987 | Factor Xa complex with GTC000422 | 4y7a | 77.33 |
52 | l1d | Crystal Structure of FXa in complex with 4,4-disubstituted pyrrolidine-1,2-dicarboxamide inhibitor 1 | 2w3k | 77.27 |
53 | 230 | An Orally Efficacious Factor Xa Inhibitor | 2phb | 77.12 |
54 | 4pp | FACTOR XA COMPLEXED WITH A SYNTHETIC INHIBITOR FX-2212A,(2S)-(3'-AMIDINO-3-BIPHENYLYL)-5-(4-PYRIDYLAMINO)PENTANOIC ACID | 1xkb | 77 |
55 | i1h | Crystal structure of factor Xa in complex with 50 | 2bmg | 76.88 |
56 | xmj | Human coagulation factor Xa in complex with M54476 | 1iql | 76.82 |
57 | y5h | FACTOR XA - CATION INHIBITOR COMPLEX | 2y5h | 76.82 |
58 | xme | Human coagulation factor Xa in complex with M55159 | 1iqg | 76.75 |
59 | xmg | Human coagulation factor Xa in complex with M55125 | 1iqi | 76.74 |
60 | rpr | CRYSTAL STRUCTURE OF HUMAN COAGULATION FACTOR XA COMPLEXED WITH RPR128515 | 1ezq | 76.72 |
61 | ik8 | Factor XA in complex with the inhibitor 1-(3'-amino-1,2-benzisoxazol-5'-yl)-n-(4-(2'-((dimethylamino)methyl)-1h-imidazol-1-yl)-2-fluorophenyl)-3-(trifluoromethyl)-1h-pyrazole-5-carboxamide (razaxaban; DPC906; BMS-561389) | 1z6e | 76.66 |
62 | 48w | Factor Xa complex with GTC000398 | 4y71 | 76.57 |
63 | bi7 | Factor Xa - cation inhibitor complex | 2jkh | 76.56 |
64 | d1q | Factor Xa in complex with D102-4380 | 3tk5 | 76.44 |
65 | pr2 | Crystal Structure of Human Coagulation Factor XA Complexed with RPR208707 | 1f0s | 76.4 |
66 | d76 | Factor Xa in complex with the inhibitor 1-[6-methyl-4,5,6,7-tetrahydrothiazolo(5,4-c)pyridin-2-yl] carbonyl-2-carbamoyl-4-(6-chloronaphth-2-ylsulphonyl)piperazine | 1v3x | 76.38 |
67 | xmf | Human coagulation factor Xa in complex with M55143 | 1iqh | 76.37 |
68 | ens | Crystal structure of human FXA in complex with methyl (2Z)-3-[(3-chloro-1H-indol-7-yl)amino]-2-cyano-3-{[(3S)-2-oxo-1-(2-oxo-2-pyrrolidin-1-ylethyl)azepan-3-yl]amino}acrylate | 3ens | 75.94 |
69 | 4qc | Factor Xa in complex with the inhibitor 3-(6-(2'-((dimethylamino)methyl)-4-biphenylyl)-7-oxo-3-(trifluoromethyl)-4,5,6,7-tetrahydro-1H-pyrazolo[3,4-c]pyridin-1-yl)benzamide | 2g00 | 75.71 |
70 | xwg | FACTOR XA - CATION INHIBITOR COMPLEX | 2y5f | 75.49 |
71 | 898 | Structure and property based design of factor Xa inhibitors: pyrrolidin-2-ones with monoaryl P4 motifs | 2wyj | 75.46 |
72 | me4 | Factor xa in complex with the inhibitor 3-chloro-N-((1R,2S)-2-(4-(2-oxopyridin-1(2H)-yl)benzamido)cyclohexyl)-1H-indole-6-carboxamide | 2p94 | 75.27 |
73 | rrp | CRYSTAL STRUCTURE OF HUMAN COAGULATION FACTOR XA COMPLEXED WITH RPR132747 | 1nfu | 75.23 |
74 | fxi | The discovery of glycine and related amino acid-based factor xa inhibitors | 2q1j | 75.05 |
75 | xld | Crystal Structure of 3-chloro-N-[4-chloro-2-[[(5-chloro-2-pyridinyl)amino]carbonyl]-6-methoxyphenyl]-4-[[(4,5-dihydro-2-oxazolyl)methylamino]methyl]-2-thiophenecarboxamide Complexed with Human Factor Xa | 1mq6 | 74.99 |
76 | 461 | Structure and property based design of factor Xa inhibitors: pyrrolidin-2-ones with monoaryl P4 motifs | 2wyg | 74.84 |
77 | jnj | X-ray Structure of FXa in complex with 7-fluoroindazole | 2ra0 | 74.51 |
78 | lg0 | FACTOR XA IN COMPLEX WITH THE INHIBITOR 1-(4-methoxyphenyl)-6-(4-(1-(pyrrolidin-1-ylmethyl)cyclopropyl)phenyl)-3-(trifluoromethyl)-5,6-dihydro-1H-pyrazolo[3,4-c]pyridin-7(4H)-one | 3cs7 | 74.5 |
79 | 993 | Crystal structure of human factor XA complexed with 3-Chloro-4-(2-methylamino-imidazol-1-ylmethyl)-thiophene-2-carboxylic acid [4-chloro-2-(5-chloro-pyridin-2-ylcarbamoyl)-6-methoxy-phenyl]-amide | 2p3t | 74.47 |
80 | lgl | Factor xa in complex with the inhibitor 1-(3-(5-oxo-4,5- dihydro-1h-1,2,4-triazol-3-yl)phenyl)-6-(2'-(pyrrolidin-1- ylmethyl)biphenyl-4-yl)-3-(trifluoromethyl)-5,6-dihydro- 1h-pyrazolo[3,4-c]pyridin-7(4h)-one | 3kqd | 74.46 |
81 | lzi | Aminopyrrolidine Factor Xa inhibitor | 2vwm | 74.43 |
82 | d92 | FACTOR XA IN COMPLEX WITH THE INHIBITOR (-)-cis-N1-[(5-Chloroindol-2-yl)carbonyl]-N2-[(5-methyl-4,5,6,7-tetrahydrothiazolo[5,4-c]pyridin-2-yl)carbonyl]-1,2-cyclohexanediamine | 2ei6 | 74.42 |
83 | 815 | CRYSTAL STRUCTURE OF HUMAN COAGULATION FACTOR XA COMPLEXED WITH RPR208815 | 1f0r | 74.19 |
84 | rdr | CRYSTAL STRUCTURE OF HUMAN COAGULATION FACTOR XA COMPLEXED WITH RPR208944 | 1nfx | 74.18 |
85 | xmk | Human coagulation factor Xa in complex with M54471 | 1iqm | 74.09 |
86 | gsi | Structure and property based design of factor Xa inhibitors:biaryl pyrrolidin-2-ones incorporating basic heterocyclic motifs | 2vh0 | 73.74 |
87 | d14 | Factor XA in complex with a cis-1,2-diaminocyclohexane derivative | 3iit | 73.73 |
88 | 237 | Factor XA inhibitor | 2pr3 | 73.3 |
89 | dx9 | COAGULATION FACTOR XA INHIBITOR COMPLEX | 1fax | 73.16 |
90 | lgm | Factor xa in complex with the inhibitor 3-methyl-1-(3-(5- oxo-4,5-dihydro-1h-1,2,4-triazol-3-yl)phenyl)-6-(2'- (pyrrolidin-1-ylmethyl)biphenyl-4-yl)-5,6-dihydro-1h- pyrazolo[3,4-c]pyridin-7(4h)-one | 3kqe | 73.08 |
91 | fi1 | X-ray crystal structure of human FXA in complex with 6-chloro-N-((3S)-2-oxo-1-(2-oxo-2-((5S)-8-oxo-5,6-dihydro-1H-1,5-methanopyrido[1,2-a][1,5]diazocin-3(2H,4H,8H)-yl)ethyl)piperidin-3-yl)naphthalene-2-sulfonamide | 3sw2 | 72.29 |
92 | xma | Human coagulation factor Xa in complex with M55532 | 1ioe | 72.25 |
93 | gsj | CRYSTAL STRUCTURE OF A HUMAN FACTOR XA INHIBITOR COMPLEX | 2j4i | 72.04 |
94 | ffg | Factor XA in complex with the inhibitor (R)-6-(2'-((3- HYDROXYPYRROLIDIN-1-YL)METHYL)BIPHENYL-4-YL)-1-(3-(5-OXO-4,5-DIHYDRO-1H-1,2,4-TRIAZOL-3-YL)PHENYL)-3-(TRIFLUOROMETHYL)-5,6-DIHYDRO-1H-PYRAZOLO[3,4-C]PYRIDIN- 7(4H)-ONE | 3ffg | 71.98 |
95 | t87 | FACTOR XA INHIBITOR COMPLEX | 1g2l | 71.73 |
96 | 4o4 | Factor Xa complex with GTC000006 | 4zh8 | 71.72 |
97 | mbm | X-ray crystal structure of human fxa in complex with (S)-N-((2-METHYLBENZOFURAN-5-YLAMINO)(2-OXO-1-(2-OXO-2- (PYRROLIDIN-1-YL)ETHYL)AZEPAN-3- YLAMINO)METHYLENE)NICOTINAMIDE | 3k9x | 71.68 |
98 | z34 | CRYSTAL STRUCTURE OF THE INHIBITOR ZK-807834 (CI-1031) COMPLEXED WITH FACTOR XA | 1fjs | 71.45 |
99 | 44i | Factor Xa complex with GTC000441 | 4y7b | 71.36 |
100 | 5qc | Factor Xa in complex with the inhibitor 1-(3-amino-1,2-benzisoxazol-5-yl)-6-(2'-(((3r)-3-hydroxy-1-pyrrolidinyl)methyl)-4-biphenylyl)-3-(trifluoromethyl)-1,4,5,6-tetrahydro-7h-pyrazolo[3,4-c]pyridin-7-one | 2fzz | 71.33 |
101 | 4o1 | Factor Xa complex with GTC000401 | 4y76 | 70.08 |
102 | xmh | Human coagulation factor Xa in complex with M55124 | 1iqj | 70.05 |
103 | dt8 | FACTOR XA IN COMPLEX WITH THE INHIBITOR (1S,2R,4S)-N1-[(5-chloroindol-2-yl)carbonyl]-4-(N,N-dimethylcarbamoyl)-N2-[(5-methyl-4,5,6,7-tetrahydrothiazolo[5,4-c]pyridin-2-yl)carbonyl]-1,2-cyclohexanediamine | 2ei8 | 67.02 |